IRB review of psychiatric medication discontinuation and symptom-provoking studies

Biological Psychiatry

Volumn 46, Issue 8, 1999, Pages 1039-1043

  Rosenstein, Donald L ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Bioethics; Challenge studies; IRB; Medication discontinuation; Safeguards; Vulnerable subjects

Indexed keywords

CONFERENCE PAPER; DRUG THERAPY; ETHICS; HUMAN; INFORMED CONSENT; INSTITUTIONAL CARE; PRIORITY JOURNAL;

BIOMEDICAL AND BEHAVIORAL RESEARCH; MENTAL HEALTH THERAPIES;

BIOETHICS; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY; HUMANS; MENTAL DISORDERS; PROFESSIONAL STAFF COMMITTEES; PSYCHIATRY; RESEARCH;

EID: 0032855902     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(99)00168-7     Document Type: Conference Paper

References (8)

1. Appelbaum P.S., Roth L.H., Lidz C.W., Benson P., Winslade W. False hopes and best data Consent to research and the therapeutic misconception . Hastings Cent Rep. 17:1987;20-24.
2. Beecher H.K. Ethics and clinical research. N Engl J Med. 274:1966;1355-1360.
3. Dresser R. Mentally disabled research subjects The enduring policy issues . JAMA. 276:1996;67-72.
4. Final Report of the Maryland Attorney General's Working Group on Research Involving Decisionally Incapacitated Subjects. 1988;MAGWG, Baltimore, MD.
5. Miller F.G., Rosenstein D.L., DeRenzo E.G. Professional integrity in clinical research. JAMA. 280:1998;1449-1454.
6. Report on Research Involving Persons With Mental Disorders that May Affect Decisionmaking Capacity. 1998;NBAC, Washington, DC.
7. Sugarman J., Kass N.E., Goodman S.N., Perentesis P., Fernandes P., Faden R.R. What patients say about medical research. IRB. 20:1998;1-7.
8. Sunderland T., Dukoff R. Surrogate decision making and advance directives with cognitively impaired research subjects. Pincus H.A., Lieberman J.A., Ferris S. Ethics in Psychiatric Research A Resource Manual for Human Subjects Protection . 1998;107-127 American Psychiatric Association, Washington, DC.